Pegylated liposomal doxorubicine: Efficacy in patients with recurrent high-grade glioma

被引：0
|
作者：
Hau, P
Grauer, O
Bock, A
Dietmaier, W
Dietrich, J
Jauch, T
Drechsel, E
Wismeth, C
Brawanski, A
Schuierer, G
Steinbrecher, A
Bogdahn, U
机构：
来源：
NEUROLOGY | 2004年 / 62卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A543 / A543
页数：1
相关论文
共 50 条
  • [1] Pegylated liposomal doxorubicin-efficacy in patients with recurrent high-grade glioma
    Hau, P
    Fabel, K
    Baumgart, U
    Rümmele, P
    Grauer, O
    Bock, A
    Dietmaier, C
    Dietmaier, W
    Dietrich, J
    Dudel, C
    Hübner, F
    Jauch, T
    Drechsel, E
    Kleiter, I
    Wismeth, G
    Zellner, A
    Brawanski, A
    Steinbrecher, A
    Marienhagen, J
    Bogdahn, U
    [J]. CANCER, 2004, 100 (06) : 1199 - 1207
  • [2] Efficacy of Reirradiation for Patients With Recurrent High-grade Glioma
    Tsutsumi, Y.
    Harada, H.
    Hirasawa, N.
    Ogawa, H.
    Asakura, H.
    Fuji, H.
    Murayama, S.
    Mitsuya, K.
    Nakasu, Y.
    Nishimura, T.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S264 - S264
  • [3] Pegylated liposomal doxorubicin in recurrent high-grade glioma: Comparison of clinical trial results and compassionate use
    Glas, M.
    Koch, H.
    Hirschmann, B.
    Jauch, T.
    Steinbrecher, A.
    Bogdahn, U.
    Hau, P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [4] Comparison of doxorubicin and a not pegylated liposomal form, doxorubicine chlorhydrate, as radiosensitizer in high grade glioma and rhabdomyosarcoma xenografts
    Chastagner, Pascal
    Aarnink, Alice
    Bernier, Valerie
    Labussiere, Marianne
    Pinel, Sophie
    [J]. PEDIATRIC BLOOD & CANCER, 2007, 49 (04) : 440 - 440
  • [5] Pegylated liposomal doxorubicin in recurrent high-grade glioma: Comparison of clinical trial results and compassionate use
    Glas, M.
    Koch, H.
    Hirschmann, B.
    Jauch, T.
    Steinbrecher, A.
    Bogdahn, U.
    Hau, P.
    [J]. NEURO-ONCOLOGY, 2006, 8 (04) : 353 - 354
  • [6] Phase I study of non-pegylated liposomal doxorubicin in children with recurrent/refractory high-grade glioma
    Pascal Chastagner
    Bénédicte Devictor
    Birgit Geoerger
    Isabelle Aerts
    Pierre Leblond
    Didier Frappaz
    Jean-Claude Gentet
    Serge Bracard
    Nicolas André
    [J]. Cancer Chemotherapy and Pharmacology, 2015, 76 : 425 - 432
  • [7] Phase I study of non-pegylated liposomal doxorubicin in children with recurrent/refractory high-grade glioma
    Chastagner, Pascal
    Devictor, Benedicte
    Geoerger, Birgit
    Aerts, Isabelle
    Leblond, Pierre
    Frappaz, Didier
    Gentet, Jean-Claude
    Bracard, Serge
    Andre, Nicolas
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 76 (02) : 425 - 432
  • [8] A phase 1 trial of intravenous liposomal irinotecan in patients with recurrent high-grade glioma
    Jennifer L. Clarke
    Annette M. Molinaro
    Juan R. Cabrera
    Ashley A. DeSilva
    Jane E. Rabbitt
    Joshua Prey
    Daryl C. Drummond
    Jaeyeon Kim
    Charles Noble
    Jonathan B. Fitzgerald
    Susan M. Chang
    Nicholas A. Butowski
    Jennie W. Taylor
    John W. Park
    Michael D. Prados
    [J]. Cancer Chemotherapy and Pharmacology, 2017, 79 : 603 - 610
  • [9] A phase 1 trial of intravenous liposomal irinotecan in patients with recurrent high-grade glioma
    Clarke, Jennifer L.
    Molinaro, Annette M.
    Cabrera, Juan R.
    DeSilva, Ashley A.
    Rabbitt, Jane E.
    Prey, Joshua
    Drummond, Daryl C.
    Kim, Jaeyeon
    Noble, Charles
    Fitzgerald, Jonathan B.
    Chang, Susan M.
    Butowski, Nicholas A.
    Taylor, Jennie W.
    Park, John W.
    Prados, Michael D.
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 79 (03) : 603 - 610
  • [10] Recurrent High-Grade Glioma
    Eudocia C. Quant
    Jan Drappatz
    Patrick Y. Wen
    Andrew D. Norden
    [J]. Current Treatment Options in Neurology, 2010, 12 : 321 - 333
12345